Cargando…
Biochemical Effect of Resistance Mutations against Synergistic Inhibitors of RSV RNA Polymerase
ALS-8112 is the parent molecule of ALS-8176, a first-in-class nucleoside analog prodrug effective in the clinic against respiratory syncytial virus (RSV) infection. The antiviral activity of ALS-8112 is mediated by its 5'-triphosphate metabolite (ALS-8112-TP, or 2'F-4'ClCH(2)-cytidine...
Autores principales: | Deval, Jerome, Fung, Amy, Stevens, Sarah K., Jordan, Paul C., Gromova, Tatiana, Taylor, Joshua S., Hong, Jin, Meng, Jia, Wang, Guangyi, Dyatkina, Natalia, Prhavc, Marija, Symons, Julian A., Beigelman, Leo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862670/ https://www.ncbi.nlm.nih.gov/pubmed/27163448 http://dx.doi.org/10.1371/journal.pone.0154097 |
Ejemplares similares
-
Molecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2'-Fluoro-4'-Chloromethyl-Cytidine Triphosphate
por: Deval, Jerome, et al.
Publicado: (2015) -
Inhibition of viral RNA polymerases by nucleoside and nucleotide analogs: therapeutic applications against positive-strand RNA viruses beyond hepatitis C virus
por: Deval, Jerome, et al.
Publicado: (2014) -
Initiation, extension, and termination of RNA synthesis by a paramyxovirus polymerase
por: Jordan, Paul C., et al.
Publicado: (2018) -
Synthesis and Anti-Hepatitis B Activities of 3′-Fluoro-2′-Substituted Apionucleosides
por: Holan, Martin, et al.
Publicado: (2022) -
Innovation and trends in the development and approval of antiviral medicines: 1987–2017 and beyond
por: Chaudhuri, Shuvam, et al.
Publicado: (2018)